Connectez-vous/S’inscrire
Votre e-mail a été envoyé.
16417 Whittier Blvd Bureau 862 m² À vendre Whittier, CA 90603 3 461 069 € (4 016,67 €/m²) Taux de capitalisation 6,10 %



Certaines informations ont été traduites automatiquement.
Informations principales sur l'investissement
- Infill Single-Tenant DaVita w/ Long Operating History and Term
- Recent Capital Improvements
- Below Market Lease and Term
- Bonus Depreciation Advantage
Résumé analytique
Infill Single-Tenant DaVita with Long Operating History and Term
* Strong Tenant and Operating History | The property presents the opportunity to own a DaVita operated dialysis clinic in an extremely infill location. The building has been operating as a Dialysis center for 20+ years, and DaVita took over the operations in 2024.
* Below Market Lease and Term | With ±7.6 years remaining on the lease with annual increases and a rent that is ±11.4% below market level, the offering provides attractive cash flow, term and upside.
* Recent Capital Improvements | Seller and Tenant have both put a considerable amount of money into the building recently with improvement projects consisting of the installation of two new HVAC units that handle patient treatment areas, new fire sprinkler system throughout the building, seismic retrofitting and exterior and rebranding.
* Bonus Depreciation Advantage | Given the new tax legislation passed July 2025, new ownership has the opportunity to accelerate the depreciation deduction in
the first year of ownership, which would provide significant upfront tax savings and improve cash flow. CBRE’s Cost Segregation Analysis estimates that such Year 1 deduction could total as much as ±$950,000 with this purchase.
* Strong Tenant and Operating History | The property presents the opportunity to own a DaVita operated dialysis clinic in an extremely infill location. The building has been operating as a Dialysis center for 20+ years, and DaVita took over the operations in 2024.
* Below Market Lease and Term | With ±7.6 years remaining on the lease with annual increases and a rent that is ±11.4% below market level, the offering provides attractive cash flow, term and upside.
* Recent Capital Improvements | Seller and Tenant have both put a considerable amount of money into the building recently with improvement projects consisting of the installation of two new HVAC units that handle patient treatment areas, new fire sprinkler system throughout the building, seismic retrofitting and exterior and rebranding.
* Bonus Depreciation Advantage | Given the new tax legislation passed July 2025, new ownership has the opportunity to accelerate the depreciation deduction in
the first year of ownership, which would provide significant upfront tax savings and improve cash flow. CBRE’s Cost Segregation Analysis estimates that such Year 1 deduction could total as much as ±$950,000 with this purchase.
Informations sur l’immeuble
Type de vente
Investissement
Type de bien
Bureau
Sous-type de bien
Médical
Surface de l’immeuble
862 m²
Classe d’immeuble
C
Année de construction
1954
Prix
3 461 069 €
Prix par m²
4 016,67 €
Taux de capitalisation
6,10 %
RNE
211 125 €
Occupation
Mono
Hauteur du bâtiment
1 étage
Surface type par étage
862 m²
Coefficient d’occupation des sols de l’immeuble
0,41
Surface du lot
0,21 ha
Zonage
R-4 - Heavy Multifamily Residential
Stationnement
35 places (40,62 places par 1 000 m² loué)
1 1
Assez praticable à pied
50/100
Moyennement adapté aux voitures
70/100
Transports en commun limités
30/100
Plutôt praticable en vélo
40/100
Taxes foncières
| Numéro de parcelle | 8233-009-009 | Évaluation des aménagements | 238 187 € |
| Évaluation du terrain | 657 566 € | Évaluation totale | 895 754 € |
Taxes foncières
Numéro de parcelle
8233-009-009
Évaluation du terrain
657 566 €
Évaluation des aménagements
238 187 €
Évaluation totale
895 754 €
1 sur 5
Vidéos
Visite extérieure 3D Matterport
Visite 3D
Photos
Street view
Rue
Carte
1 sur 1
Présenté par
16417 Whittier Blvd
Vous êtes déjà membre ? Connectez-vous
Hum, une erreur s’est produite lors de l’envoi de votre message. Veuillez réessayer.
Merci ! Votre message a été envoyé.
